N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in Vivo
Open Access
- 1 December 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (48), 41626-41635
- https://doi.org/10.1074/jbc.m111.257915
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Alternative Macrophage Activation and MetabolismAnnual Review Of Pathology-Mechanisms Of Disease, 2011
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5Nature, 2010
- A Functional Peroxisome Proliferator-activated Receptor-γ Ligand-binding Domain Is Not Required for AdipogenesisPublished by Elsevier BV ,2008
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Modulation of PPAR activity via phosphorylationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007
- Inflammation and metabolic disordersNature, 2006
- Adipocyte differentiation from the inside outNature Reviews Molecular Cell Biology, 2006
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994